rxstat › Shortages › Chloride Thrombin Aprotinin Sealer Protein

Chloride Thrombin Aprotinin Sealer Protein (Tisseel, Artiss) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Oct 13, 2026

Some Chloride Thrombin Aprotinin Sealer Protein products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 15, 2026.
Products affected
1 / 2
In shortage since
Oct 8, 2026
Est. full return
Dec 15, 2026
Reports on file
6
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TISSEEL
3000KIU 500UNIT 125MG 40MCMOL · KIT · BAXTER CORPORATION
DIN 02326132 · since Oct 8, 2026, no end estimate · Delay in shipping of the drug.
Active shortage
TISSEEL
3000KIU 500UNIT 125MG 40MCMOL · KIT · BAXTER CORPORATION
DIN 02326132 · since Oct 8, 2026, est. end Dec 15, 2026 · Delay in shipping of the drug.
Active shortage
TISSEEL
3000KIU 500UNIT 125MG 40MCMOL · KIT · BAXTER CORPORATION
DIN 02326132 · since Oct 8, 2026, est. end Dec 15, 2026 · Delay in shipping of the drug.
Resolved
TISSEEL
40MCMOL 500UNIT 3000KIU 125MG · KIT · BAXTER CORPORATION
DIN 02326132 · ended Oct 25, 2024 · Disruption of the manufacture of the drug.
Resolved
TISSEEL
40MCMOL 500UNIT 3000KIU 125MG · KIT · BAXTER CORPORATION
DIN 02326132 · ended Oct 25, 2024 · Disruption of the manufacture of the drug.
Resolved
ARTISS
40MCMOL 4UNIT 3000KIU 125MG · SOLUTION · BAXTER CORPORATION
DIN 02326167 · ended Jul 19, 2022 · Delay in shipping of the drug.

What's happening

Chloride Thrombin Aprotinin Sealer Protein is currently affected by an active shortage report filed with Health Canada by BAXTER CORPORATION.

The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Chloride Thrombin Aprotinin Sealer Protein is classified under “VITAMIN K AND OTHER HEMOSTATICS” (ATC B02BC).

Recent changes

Common questions

When will Chloride Thrombin Aprotinin Sealer Protein be back in stock in Canada?

The latest manufacturer estimate is Dec 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Chloride Thrombin Aprotinin Sealer Protein in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (vitamin k and other hemostatics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.